The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Bioactive benzofuran derivatives: An insight on lead developments, radioligands and advances of the last decade
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
Increased anxiety of mice lacking the serotonin 1A receptor
Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T., & Toth, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10734 · Cited by 691
A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase
Greig, N. H., Utsuki, T., Yu, Q.-S., Zhu, X., Holloway, H. W., Perry, T., Lee, B., Ingram, D. K., & Lahiri, D. K. (2001) · Current Medical Research and Opinion · doi:10.1185/03007990152673800 · Cited by 493
Histone Deacetylase Inhibitors: From Bench to Clinic
Paris, M., Porcelloni, M., Binaschi, M., & Fattori, D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7011408 · Cited by 367
Kau, T. R., Schroeder, F., Ramaswamy, S., Wojciechowski, C. L., Zhao, J. J., Roberts, T. M., Clardy, J., Sellers, W. R., & Silver, P. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00303-9 · Cited by 329
Liang, J., & Shang, Y. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183708 · Cited by 314
Dopamine receptor subtypes: beyond the D1/D2 classification
Andersen, P. H., Gingrich, J. A., Bates, M. D., Dearry, A., Falardeau, P., Senogles, S. E., & Caron, M. G. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90249-8 · Cited by 293
Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State
Santagata, S., Mendillo, M. L., Tang, Y.-C., Subramanian, A., Perley, C. C., Roche, S. P., Wong, B., Narayan, R., Kwon, H., Koeva, M., et al. (2013) · Science · doi:10.1126/science.1238303 · Cited by 285
Rifampicin: A New Orally Active Rifamycin
Maggi, N., Pasqualucci, C. R., Ballotta, R., & Sensi, P. (1966) · Chemotherapy · doi:10.1159/000220462 · Cited by 270
Adenosine A2A and Dopamine D2 Heteromeric Receptor Complexes and Their Function
Fuxe, K., Ferré, S., Canals, M., Torvinen, M., Terasmaa, A., Marcellino, D., Goldberg, S. R., Staines, W., Jacobsen, K. X., Lluis, C., et al. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:26:2-3:209 · Cited by 235
On and Around Microtubules: An Overview
Wade, R. H. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9193-5 · Cited by 232
Amson, R., Sigaux, F., Przedborski, S., Flandrin, G., Givol, D., & Telerman, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8857 · Cited by 231
Kennett, G. A., Dourish, C. T., & Curzon, G. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90357-8 · Cited by 228
Melatonin: therapeutic and clinical utilization
Altun, A., & Ugur-Altun, B. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01191.x · Cited by 219
Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands
Maurice, T., & Lockhart, B. P. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00160-1 · Cited by 211
Rizzo, S., Rivière, C., Piazzi, L., Bisi, A., Gobbi, S., Bartolini, M., Andrisano, V., Morroni, F., Tarozzi, A., Monti, J.-P., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002747 · Cited by 189
Lu King, M., Chiang, C.-C., Ling, H.-C., Fujita, E., Ochiai, M., & McPhail, A. T. (1982) · Journal of the Chemical Society, Chemical Communications · doi:10.1039/c39820001150 · Cited by 187
The histamine H3 receptor as a therapeutic drug target for CNS disorders
Gemkow, M. J., Davenport, A. J., Harich, S., Ellenbroek, B. A., Cesura, A., & Hallett, D. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.011 · Cited by 181
mTOR mediated anti-cancer drug discovery
Liu, Q., Thoreen, C., Wang, J., Sabatini, D., & Gray, N. S. (2009) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2009.12.001 · Cited by 174
Current Trends in the Development of New Antidepressants
Pacher, P., Kohegyi, E., Kecskemeti, V., & Furst, S. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373796 · Cited by 160
Flynn, B. L., Gill, G. S., Grobelny, D. W., Chaplin, J. H., Paul, D., Leske, A. F., Lavranos, T. C., Chalmers, D. K., Charman, S. A., Kostewicz, E. S., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200454y · Cited by 154
Novel Spiropiperidines as Highly Potent and Subtype Selective σ-Receptor Ligands. Part 1
Maier, C. A., & Wünsch, B. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010992z · Cited by 152
Challenges, controversies, breakthroughs
Hutchinson, L. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.192 · Cited by 150
Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists
Uchikawa, O., FUKATSU, K., Tokunoh, R., Kawada, M., Matsumoto, K., Imai, Y., Hinuma, S., Kato, K., Nishikawa, H., Hirai, K., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0201159 · Cited by 143
Gaisina, I. N., Gallier, F., Ougolkov, A. V., Kim, K. H., Kurome, T., Guo, S., Holzle, D. L., Luchini, D. N., Blond, S. Y., Billadeau, D. D., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801317h · Cited by 132
Benzofuran derivatives as Aβ-aggregate-specific imaging agents for Alzheimer’s disease
Ono, M., Kung, M., Hou, C., & Kung, H. F. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00326-8 · Cited by 131
Saitoh, M., Kunitomo, J., Kimura, E., Iwashita, H., Uno, Y., Onishi, T., Uchiyama, N., Kawamoto, T., Tanaka, T., Mol, C. D., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900647e · Cited by 130
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor
Karlsson, P., Farde, L., Halldin, C., Swahn, C., Sedvall, G., Foged, C., Hansen, K. T., & Skrumsager, B. K. (1993) · Psychopharmacology · doi:10.1007/bf02245691 · Cited by 128
Buggy, J. J., Cao, Z. A., Bass, K. E., Verner, E., Balasubramanian, S., Liu, L., Schultz, B. E., Young, P. R., & Dalrymple, S. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0442 · Cited by 127
Thuaud, F., Bernard, Y., Türkeri, G., Dirr, R., Aubert, G., Cresteil, T., Baguet, A., Tomasetto, C., Svitkin, Y. V., Sonenberg, N., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900365v · Cited by 125
Alquier, T., Peyot, M., Latour, M. G., Kebede, M. A., Sorensen, C. M., Gesta, S., Kahn, C. R., Smith, R. D., Jetton, T. L., Metz, T., et al. (2009) · Diabetes · doi:10.2337/db09-0362 · Cited by 125
Insecticidal 1H-cyclopentatetrahydro[b]benzofurans from Aglaia odorata
Ishibashi, F., Satasook, C., Ismant, M. B., & Towers, G. H. N. (1993) · Phytochemistry · doi:10.1016/s0031-9422(00)94986-0 · Cited by 124
Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity
Marrazzo, A., Caraci, F., Salinaro, E. T., Su, T., Copani, A., & Ronsisvalle, G. (2005) · Neuroreport · doi:10.1097/00001756-200508010-00018 · Cited by 120
Halldin, C., Foged, C., Chou, Y.-H., Karlsson, P., Swahn, C.-G., Sandell, J., Sedvall, G., & Farde, L. (1998) · PubMed · Cited by 119
Heinrich, T., Böttcher, H., Gericke, R., Bartoszyk, G. D., Anzali, S., Seyfried, C. A., Greiner, H. E., & van Amsterdam, C. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040793q · Cited by 119
Novel Benzofuran Derivatives for PET Imaging of β-Amyloid Plaques in Alzheimer's Disease Brains
Ono, M., Kawashima, H., Nonaka, A., Kawai, T., Haratake, M., Mori, H., Kung, M., Kung, H. F., Saji, H., & Nakayama, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051176k · Cited by 107
Rocaglamide Derivatives Are Potent Inhibitors of NF-κB Activation in T-cells
Baumann, B., Bohnenstengel, F. I., Siegmund, D., Wajant, H., Weber, C. K., Herr, I., Debatin, K., Proksch, P., & Wirth, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208003200 · Cited by 98
Kozikowski, A. P., Gaisina, I. N., Yuan, H., Petukhov, P. A., Blond, S. Y., Fedolak, A., Caldarone, B. J., & McGonigle, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068969w · Cited by 89
Honer, M., Gobbi, L. B., Martarello, L., & Comley, R. A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.012 · Cited by 86
Negoro, N., Sasaki, S., Mikami, S., Ito, M., Tsujihata, Y., Ito, R., Suzuki, M., Takeuchi, K., Suzuki, N., Miyazaki, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300170m · Cited by 85
Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184
Nyberg, S., Eriksdotter, M., Cselényi, Z., Halldin, C., Julin, P., Olsson, H., Freund‐Levi, Y., Andersson, J. D., Varnäs, K., Svensson, S., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1182-1 · Cited by 85
Aoyagi, T., Wada, T., NAGAI, M., Kojima, F., Harada, S., Takeuchi, T., Takahashi, H., Hirokawa, K., & Tsumita, T. (1990) · Cellular and Molecular Life Sciences · doi:10.1007/bf01955428 · Cited by 83
Ono, M., Cheng, Y., Kimura, H., Cui, M., Kagawa, S., Nishii, R., & Saji, H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200057u · Cited by 83
Designer psychostimulants: Pharmacology and differences
Iversen, L. L., White, M., & Treble, R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.015 · Cited by 76
Rocaglamide Derivatives Are Immunosuppressive Phytochemicals That Target NF-AT Activity in T Cells
Proksch, P., Giaisi, M., Treiber, M. K., Pálfi, K., Merling, A., Spring, H., Krammer, P. H., & Li‐Weber, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7075 · Cited by 74
Novel Radioiodinated Aurones as Probes for SPECT Imaging of β-Amyloid Plaques in the Brain
Maya, Y., Ono, M., Watanabe, H., Haratake, M., Saji, H., & Nakayama, M. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8003292 · Cited by 73
Cheng, Y., Ono, M., Kimura, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201513c · Cited by 72
Moussa, I. A., Banister, S. D., Beinat, C., Giboureau, N., Reynolds, A. J., & Kassiou, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100639f · Cited by 71
Positron emission tomography radioligands for in vivo imaging of Aβ plaques
Mason, N. S., Mathis, C. A., & Klunk, W. E. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2989 · Cited by 69
Pfefferkorn, J. A., Guzmán-Pérez, A., Oates, P. J., Litchfield, J., Aspnes, G. E., Basak, A., Benbow, J. W., Berliner, M. A., Bian, J., Choi, C., et al. (2011) · MedChemComm · doi:10.1039/c1md00116g · Cited by 69
Fischer, S., Wiese, C., Maestrup, E. G., Hiller, A., Deuther‐Conrad, W., Scheunemann, M., Schepmann, D., Steinbach, J., Wünsch, B., & Brust, P. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1658-z · Cited by 68
Koek, W., Patoiseau, J., Assié, M. B., Cosi, C., Kleven, M. S., Dupont-Passelaigue, E., Carilla-Durand, E., Palmier, C., Valentin, J., John, G. W., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37788-2 · Cited by 66
HIF-1α inhibitors: Synthesis and biological evaluation of novel moracin O and P analogues
Xia, Y., Jin, Y., Kaur, N., Choi, Y., & Lee, K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.03.022 · Cited by 62
McCreary, A. C., Glennon, J. C., Ashby, C. R., Meltzer, H. Y., Li, Z., Reinders, J. H., Hesselink, M. B., Long, S., Herremans, A. H. J., van Stuivenberg, H. H., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301098 · Cited by 59
Glucokinase activators as new type 2 diabetes therapeutic agents
Sarabu, R., Berthel, S. J., Kester, R. F., & Tilley, J. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.7.759 · Cited by 58
Dawson, P., Opacka‐Juffry, J., Moffatt, J. D., Daniju, Y., Dutta, N., Ramsey, J., & Davidson, C. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.013 · Cited by 56
Varasi, M., Thaler, F., Abate, A., Bigogno, C., Boggio, R., Carenzi, G. E. A., Cataudella, T., Zuffo, R. D., Fulco, M. C., Rozio, M. G., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200146u · Cited by 55
Maestrup, E. G., Fischer, S., Wiese, C., Schepmann, D., Hiller, A., Deuther‐Conrad, W., Steinbach, J., Wünsch, B., & Brust, P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900909e · Cited by 50
Towards a New Generation of Potential Antipsychotic Agents Combining D2and 5-HT1AReceptor Activities
Cuisiat, S. V., Bourdiol, N., Lacharme, V., Newman‐Tancredi, A., Colpaert, F. C., & Vacher, B. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061180b · Cited by 45
Rabiner, E. A., Gunn, R. N., Wilkins, M. R., Sedman, E., & Grasby, P. M. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600301 · Cited by 42
Alinari, L., Prince, C. J., Edwards, R. B., Towns, W. H., Mani, R., Lehman, A., Zhang, X., Jarjoura, D. G., Pan, L., Kinghorn, A. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0839 · Cited by 42
Synthesis and structure–activity relationships of novel benzofuran farnesyltransferase inhibitors
Asoh, K., Kohchi, M., Hyoudoh, I., Ohtsuka, T., Masubuchi, M., Kawasaki, K., Ebiike, H., Shiratori, Y., Fukami, T. A., Kondoh, O., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.074 · Cited by 41
Saku, O., Saki, M., Kurokawa, M., Ikeda, K., Takizawa, T., & Uesaka, N. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.028 · Cited by 41
Benzofuran derivatives as anticancer inhibitors of mTOR signaling
Salomé, C., Ribeiro, N., Chavagnan, T., Thuaud, F., Serova, M., Gramont, A. D. E., Faivre, S. J., Raymond, É., & Désaubry, L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.014 · Cited by 40
Satasook, C., Isman, M. B., & Wiriyachitra, P. (1992) · Pesticide Science · doi:10.1002/ps.2780360109 · Cited by 37
Tordera, R. M., Monge, A., Rı́o, J. D., & Lasheras, B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01504-2 · Cited by 30
Current status of positron emission tomography radiotracers for serotonin receptors in humans
Zimmer, L., & Bars, D. L. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3001 · Cited by 27
Li, Y., Wang, X., Zhang, J., Deuther‐Conrad, W., Xie, F., Zhang, X., Liu, J., Qiao, J., Cui, M., Steinbach, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301734g · Cited by 26
Swahn, B., Sandell, J., Pyring, D., Bergh, M., Jeppsson, F., Juréus, A., Neelissen, J. A. M., Johnström, P., Schou, M., & Svensson, S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.011 · Cited by 25
Kynapcin-13 and -28, New Benzofuran Prolyl Endopeptidase Inhibitors from Polyozellus multiplex.
Kim, S., Park, I., & Song, K. (2002) · The Journal of Antibiotics · doi:10.7164/antibiotics.55.623 · Cited by 24
Lapierre, Y. D., Silverstone, P. H., Reesal, R. T., Saxena, B. M., Turner, P., Bakish, D., Plamondon, J., Vincent, P. M., Remick, R. A., Kroft, C. D. L., et al. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199808000-00002 · Cited by 22
Maisonial‐Besset, A., Maestrup, E. G., Fischer, S., Hiller, A., Scheunemann, M., Wiese, C., Schepmann, D., Steinbach, J., Deuther‐Conrad, W., Wünsch, B., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100108 · Cited by 21
Maisonial‐Besset, A., Maestrup, E. G., Wiese, C., Hiller, A., Schepmann, D., Fischer, S., Deuther‐Conrad, W., Steinbach, J., Brust, P., & Wünsch, B. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.11.002 · Cited by 21
Saku, O., Saki, M., Kurokawa, M., Ikeda, K., Uchida, S., Takizawa, T., & Uesaka, N. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.058 · Cited by 18
Discovery of novel orally bioavailable GPR40 agonists
Lu, H., Fei, H., Yang, F., Zheng, S., Hu, Q., Zhang, L. J., Yuan, J., Feng, J., Sun, P., & Dong, Q. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.060 · Cited by 14
Moussa, I. A., Banister, S. D., Giboureau, N., Meikle, S. R., & Kassiou, M. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.028 · Cited by 13
Wiese, C., Maestrup, E. G., Schepmann, D., Grimme, S., Humpf, H., Brust, P., & Wünsch, B. (2010) · Chirality · doi:10.1002/chir.20893 · Cited by 13
Effect of the aromatase inhibitor, MEN 11066, on growth of two different MCF-7 sublines
Palma, C., Criscuoli, M., Lippi, A., Muratori, M., Mauro, S., & Maggi, C. A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00761-5 · Cited by 10
Optimizing glucokinase activator binding kinetics to lower in vivo hypoglycemia risk
Borzilleri, K. A., Pfefferkorn, J. A., Guzmán-Pérez, A., Liu, S., Qiu, X., Chrunyk, B. A., Song, X., Tu, M., Filipski, K. J., Aiello, R. J., et al. (2014) · MedChemComm · doi:10.1039/c4md00027g · Cited by 10
Usha, L., Dehghan-Paz, I., van Golen, K. L., & Il’yasova, D. (2013) · Orphan Drugs Research and Reviews · doi:10.2147/odrr.s35339 · Cited by 4
Cited by
Natural source, bioactivity and synthesis of benzofuran derivatives
Miao, Y.-H., Hu, Y.-H., Yang, J., Liu, T., Sun, J., & Wang, X.-J. (2019) · RSC Advances · doi:10.1039/c9ra04917g · Cited by 354
Zhang, H., Xu, H., Ashby, C. R., Assaraf, Y. G., Chen, Z., & Liu, H. (2021) · Medicinal Research Reviews · doi:10.1002/med.21739 · Cited by 270
Metadata
- Authors
- Radadiya, A., & Shah, A.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 97
- Pages
- 356-376
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2043735619
- Cited by
- 264
- References
- 84
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.